Disease
7 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 11, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a registered but not-yet-recruiting study describing planned validation of a culturally adapted cognitive screening tool; no results are reported.
This is an active registry record for an observational feasibility study of a novel tau-PET tracer with no results yet posted; it describes planned safety and biodistribution assessment in 20 participants.
This is a completed Phase 2 pilot study with very small enrollment (n=5) assessing only safety and tolerability of fisetin; no efficacy results are reported in this registry record.
AUG 13, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1, open-label dose escalation study in early recruitment that has not yet posted results; it represents first-in-human work designed to characterize safety and tolerability.
AUG 10, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a completed trial registration with no posted results; the study design is sound (RCT, n=24) but outcome data are not yet reported, making it a prospective record of a small pilot-stage intervention.
JUL 31, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is an active registry record describing a planned interventional study with no results posted; evidence quality cannot be assessed until completion and outcome reporting.
JUL 31, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1 registry record for a planned interventional study with no results posted; it describes study design and enrollment targets only.